A detailed history of 55 I, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 55 I, LLC holds 38,540 shares of BMY stock, worth $2.23 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
38,540
Previous 13,407 187.46%
Holding current value
$2.23 Million
Previous $1.03 Million 165.5%
% of portfolio
0.08%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $3,267 - $1.93 Million
25,133 Added 187.46%
38,540 $2.74 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $478,493 - $526,988
6,589 Added 96.64%
13,407 $1.03 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $76,972 - $92,297
1,252 Added 22.49%
6,818 $497,000
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $373,372 - $435,264
-6,962 Reduced 55.57%
5,566 $346,000
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $741,281 - $868,315
12,528 New
12,528 $742,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track 55 I, LLC Portfolio

Follow 55 I, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 55 I, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 55 I, LLC with notifications on news.